Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated MalariaBenjamin R. Taft, Christopher R. Sarko, Richard S.P. Huang et al.|Journal of Medicinal Chemistry|2022Cited by 32
Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistanceWei Shu, Weiwei Gao, Qiping Ge et al.|Unknown|2021Cited by 0